AR073654A1 - Proceso para la sintesis del (aib8,35) hglp-1(7-36) -nh2 - Google Patents

Proceso para la sintesis del (aib8,35) hglp-1(7-36) -nh2

Info

Publication number
AR073654A1
AR073654A1 ARP090103632A ARP090103632A AR073654A1 AR 073654 A1 AR073654 A1 AR 073654A1 AR P090103632 A ARP090103632 A AR P090103632A AR P090103632 A ARP090103632 A AR P090103632A AR 073654 A1 AR073654 A1 AR 073654A1
Authority
AR
Argentina
Prior art keywords
ala
glu
ser
aib
thr
Prior art date
Application number
ARP090103632A
Other languages
English (en)
Original Assignee
Ipsen Mfg Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Mfg Ireland Ltd filed Critical Ipsen Mfg Ireland Ltd
Publication of AR073654A1 publication Critical patent/AR073654A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente solicitud se relaciona con un proceso para la síntesis a gran escala del (Aib8'35)hGLP-1(7-36)-NH2 (SEC. ID. Ns:2), es decir, His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2 (SEC. ID Ns:2), que comprende química Fmoc en fase solida. Reivindicacion 2: Un proceso para la síntesis del (Aib8'35)hGLP-1(7-36)-NH2 (SEC. ID. Ns:2) de acuerdo con la reivindicacion 1, que comprende los siguientes pasos: (a) acoplar en forma sucesiva aminoácidos Fmoc, desde el C-terminal hasta el N-terminal del (Aib8,35)hGLP-1(8-35)-NH2 (SEC. ID. Ns:8), con una resina Arg protegida con cadena lateral, donde se elimina el grupo Fmoc del N-terminal después de cada paso de acoplamiento sucesivo, para obtener una resina Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Giy-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg protegida con cadena lateral (SEC ID Ns:4); (b) acoplar el Boc-His-OH protegido con cadena lateral con la resina Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Giy-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg protegida con cadena lateral (SEC. ID. Ns:4), para obtener una resina Boc-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg protegida con cadena lateral (SEC. ID. Ns:5); (c) tratar la resina Boc-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr -Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-lle-Ala-Trp-Leu-Val-Lys-Aib-Arg protegida con cadena lateral (SEC. ID. Ns:5) con un coctel de segmentacion y eliminar los grupos protectores de cadena lateral y el grupo protector del N-terminal de aquella, para obtener el (Aib8,35)hGLP-1(7-36)-NH2 crudo (SEC. ID. Ns:2); y (d) aislar y purificar el (Aib8,35)hGLp-1(7-36)-NH2 crudo (SEC. ID. Ns:2), para obtener el (Aib8,35)hGLP-1(7-36)-NH2 purificado (SEC. ID. Ns:2).
ARP090103632A 2008-09-22 2009-09-22 Proceso para la sintesis del (aib8,35) hglp-1(7-36) -nh2 AR073654A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19293908P 2008-09-22 2008-09-22

Publications (1)

Publication Number Publication Date
AR073654A1 true AR073654A1 (es) 2010-11-24

Family

ID=42039799

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103632A AR073654A1 (es) 2008-09-22 2009-09-22 Proceso para la sintesis del (aib8,35) hglp-1(7-36) -nh2

Country Status (13)

Country Link
US (1) US20130030148A1 (es)
EP (1) EP2334316A4 (es)
JP (1) JP2012502992A (es)
KR (1) KR20110070870A (es)
CN (1) CN102223890B (es)
AR (1) AR073654A1 (es)
AU (1) AU2009293665A1 (es)
BR (1) BRPI0918993A2 (es)
CA (1) CA2737770A1 (es)
EA (1) EA201170477A1 (es)
MX (1) MX2011002885A (es)
TW (1) TW201012829A (es)
WO (1) WO2010033254A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110313131A1 (en) * 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
WO2014077802A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification method of a glp-1 analogue
MX365465B (es) 2013-03-21 2019-06-04 Sanofi Aventis Deutschland Sintesis de productos peptidicos que contienen imida ciclica.
SG11201506804VA (en) 2013-03-21 2015-09-29 Sanofi Aventis Deutschland Synthesis of hydantoin containing peptide products
KR102251970B1 (ko) * 2015-05-07 2021-05-14 삼성전자 주식회사 풀 듀플렉스 방식을 지원하는 통신 시스템에서 자기 간섭 신호 제거 장치 및 방법
CN111065631B (zh) * 2017-12-06 2021-10-08 江苏恒瑞医药股份有限公司 一种苯基丙酰胺类衍生物的盐及其制备方法
US11753440B2 (en) 2018-06-05 2023-09-12 Dsm Ip Assets B.V. Methods for the synthesis of arginine-containing peptides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07242696A (ja) * 1990-08-10 1995-09-19 Enichem Partecipazioni Spa 植物病原体に対して活性な抗菌性ペプチド、その使用法およびこれに関連するスクリーニング法
WO1992015317A1 (en) * 1991-03-08 1992-09-17 Amylin Pharmaceuticals, Inc. Synthetic preparation of amylin and amylin analogues
WO2000034331A2 (en) * 1998-12-07 2000-06-15 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Analogues of glp-1
WO2000069911A1 (en) * 1999-05-17 2000-11-23 Conjuchem, Inc. Long lasting insulinotropic peptides
JP2007536214A (ja) * 2003-12-16 2007-12-13 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Ｇｌｐ−１類似体
AU2004298424A1 (en) * 2003-12-18 2005-06-30 Novo Nordisk A/S Novel GLP-1 compounds
US7897724B2 (en) * 2004-10-10 2011-03-01 Usv, Ltd. Solid phase Fmoc chemistry process to prepare peptides
US20100009907A1 (en) * 2006-07-06 2010-01-14 Amylin Pharmaceuticals, Inc. Glucagon-Like Peptides and Uses Thereof

Also Published As

Publication number Publication date
CA2737770A1 (en) 2010-03-25
KR20110070870A (ko) 2011-06-24
MX2011002885A (es) 2011-05-31
US20130030148A1 (en) 2013-01-31
AU2009293665A1 (en) 2010-03-25
CN102223890A (zh) 2011-10-19
EA201170477A1 (ru) 2011-10-31
EP2334316A1 (en) 2011-06-22
JP2012502992A (ja) 2012-02-02
BRPI0918993A2 (pt) 2019-09-24
TW201012829A (en) 2010-04-01
EP2334316A4 (en) 2013-01-09
CN102223890B (zh) 2015-02-11
WO2010033254A8 (en) 2012-05-24
WO2010033254A1 (en) 2010-03-25

Similar Documents

Publication Publication Date Title
AR073654A1 (es) Proceso para la sintesis del (aib8,35) hglp-1(7-36) -nh2
MX2019006711A (es) Sintesis de liraglutida.
CO6400148A2 (es) Proceso para la producción de bivalirudina
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
ES2571879T3 (es) Moléculas de una sola cadena de TNFSF
EA201290370A1 (ru) Антитела против flt3 и способы их применения
MX2012008927A (es) Proceso para recuperar etanol.
WO2015027258A3 (de) Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren
GB2472350A (en) Carbon dioxide purification
RS51281B (sr) Sinteza insulinotropičnog peptida
NZ743910A (en) Purification of iduronate-2-sulfatase
BR112012027893A2 (pt) peptídeo para aumento da bioestabilidade de substância bioativa e substância biotiva que possui bioestabilidade aumentada.
WO2010117725A3 (en) Production of peptides containing poly-gly sequences using fmoc chemistry
WO2014037565A3 (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
ES2531054T3 (es) Condensación de fragmento de oligopéptido de cadena lateral protegida mediante el uso de subtilisinas en disolventes orgánicos
WO2009066462A1 (ja) 細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン
IN2012DN05886A (es)
AR083766A1 (es) Peptido inmunogenico
ES2571443T3 (es) Método mejorado para la fabricación de un inhibidor de la dipeptidil peptidasa-IV y de un intermedio
DE602004031522D1 (de) Ein tag für die reinigung von peptiden
MX2020011844A (es) Anticuerpos bispecificos con marcadores con emparejamiento de cargas c-terminales escindibles.
WO2011014780A3 (en) A process for separating one or more aliphatic diamines from reductive amination reaction solvents and impurities
MX2010010177A (es) Fragmentos de beta timosina mejorada.
Ramapanicker et al. Applications of Propargyl Esters of Amino Acids in Solution‐Phase Peptide Synthesis
AR083536A1 (es) Enlazante dipeptidilo que forma dicetopiperazina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal